National Health Investors (NHI)
(Delayed Data from NYSE)
$71.33 USD
+1.47 (2.10%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $71.35 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
NHI 71.33 +1.47(2.10%)
Will NHI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NHI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NHI
Xenia Hotels & Resorts (XHR) Tops Q2 FFO and Revenue Estimates
STRW or NHI: Which Is the Better Value Stock Right Now?
NHI: What are Zacks experts saying now?
Zacks Private Portfolio Services
National Health Investors (NHI) Q1 FFO and Revenues Beat Estimates
Centerspace (CSR) Matches Q1 FFO Estimates
CUZ vs. NHI: Which Stock Is the Better Value Option?
Other News for NHI
National Health Investors Inc (NHI) Announces Q2 2025 Earnings Release and Conference Call | ...
NHI Announces Second Quarter 2025 Earnings Release and Conference Call Dates | NHI Stock News
Welltower: A Thriving Business With Strong Secular Tailwinds Selling At A Premium
National Health Investors (NHI) Receives Keybanc Upgrade and New Price Target | NHI Stock News
KeyBanc Upgrades National Health Investors (NHI) with Promising Outlook | NHI Stock News